Drive thru, prevent flu

Swanson, Lynne
November 2003
CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1197
Academic Journal
Reports on the launch of a drive-in clinic which offer flu-shots by Middlesex-London Health Unit in Ontario on October 18, 2003. Reason for offering the service; Significance of the service to frail and disabled people; Number of slots available daily in the drive-in clinic.


Related Articles

  • Independent Nurse: Ambiguity over flu jabs in asthma.  // GP: General Practitioner;3/3/2006, p75 

    The article reports that confusion surrounds in Great Britain whether or not asthma sufferers should continue to receive flu vaccines following changes to the QOF. However, under the flu directed enhanced service, at-risk groups, which still include asthma sufferers, will continue to receive the...

  • Reports of Expired Live Attenuated Influenza Vaccine Being Administered -- United States, 2007-2014. Haber, Penina; Schembri, Christopher P.; Lewis, Paige; Hibbs, Beth; Shimabukuro, Tom // MMWR: Morbidity & Mortality Weekly Report;9/5/2014, Vol. 63 Issue 35, p773 

    The article presents information on reports of expired live attenuated influenza vaccine (LAIV) administered between 2007-2014 in the U.S. There are two types of vaccine that are approved in the U.S. including injectable inactivated influenza vaccine (IIV) and LAIV. According to a report, from...

  • Effectiveness of half-dose versus full-dose influenza vaccine in health care workers. Kramer, Joan S.; Durham, Chris; Schroeder, Todd; Garrelts, James C. // American Journal of Health-System Pharmacy;11/1/2006, Vol. 63 Issue 21, p2111 

    Purpose. A prospective, randomized, double-blind study comparing the effectiveness of half-dose versus full-dose trivalent inactivated influenza vaccine (TIV) in health care workers was conducted. Methods. The study was conducted at a 760-bed tertiary care community hospital. Study participants...

  • Randomized, Double-Blind Comparative Trial of Subunit and Virosomal Influenza Vaccines for Immunocompromised Patients. Evison, John; Farese, Stefan; Seitz, Michael; Uehlinger, Dominik E.; Furrer, Hansjakob; Mühlemann, Kathrin // Clinical Infectious Diseases;5/15/2009, Vol. 48 Issue 10, p1402 

    Background. To our knowledge, no study to date has compared the effects of a subunit influenza vaccine with those of a virosomal influenza vaccine on immunocompromised patients. Methods. A prospective, double-blind, randomized study was conducted to compare the immunogenicity and reactogenicity...

  • The Effect of Universal Influenza Immunization on Mortality and Health Care Use. Kwong, Jeffrey C.; Stukel, Thére se A.; Lim, Jenny; McGeer, Allison J.; Upshur, Ross E. G.; Johansen, Helen; Sambell, Christie; Thompson, William W.; Thiruchelvam, Deva; Marra, Fawziah; Svenson, Lawrence W.; Manuel, Douglas G. // PLoS Medicine;Oct2008, Vol. 5 Issue 10, p1440 

    Background In 2000, Ontario, Canada, initiated a universal influenza immunization program (UIIP) to provide free influenza vaccines for the entire population aged 6 mo or older. Influenza immunization increased more rapidly in younger age groups in Ontario compared to other Canadian provinces,...

  • Inactivated influenza vaccine prevented influenza in healthy adults. Ohmit, S. E.; Victor, J. C.; Rotthoff, J. R. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p60 

    The article presents a study which examines the prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. Two placebo groups were combined for the efficacy analysis. The inactivated influenza vaccine had a higher rate of vaccine efficacy than did placebo for each...

  • Inactivated influenza vaccine prevented influenza in healthy adults: COMMENTARY. Granwehr, Bruno // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p60 

    The article comments on the research conducted by S. E. Ohmit and his colleagues, which addresses the efficacy of intranasal live attenuated and injected inactivated influenza vaccines in a community-based trial. The author stressed that the increased interest in universal influenza vaccination...

  • MF59 Is a Safe and Potent Vaccine Adjuvant for Flu Vaccines in Humans: What Did We Learn During Its Development? O'Hagan, D. T.; Wack, A.; Podda, A. // Clinical Pharmacology & Therapeutics;Dec2007, Vol. 82 Issue 6, p740 

    The MF59 adjuvant has been included in a licensed influenza vaccine for a decade. Hence, we have a significant amount of clinical data to establish its potency and safety. We can now reassess our early preclinical studies and determine whether or not they were useful to predict human responses....

  • Review: Vaccination reduces the incidence of serologically confirmed influenza in healthy adults.  // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p70 

    This article presents a study, which reports that vaccination reduces the incidence of serologically confirmed influenza (SCI) in healthy adults. The study method consisted of quasirandomized or randomized controlled trials that evaluated the effectiveness of influenza vaccines for protection...

  • Influenza vaccine supply, 2005-2006: did we come up short? Bardenheier, Barbara H.; Strikas, Raymond; Kempe, Allison; Stokley, Shannon; Ellis, Jean // BMC Health Services Research;2007, Vol. 7, p66 

    Background: Although total influenza vaccine doses available in the 2005/2006 influenza season were over 80 million, CDC received many reports of delayed and diminished vaccine shipments in October to November of 2005. To better understand the supply problems, CDC and partners surveyed several...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics